Mechanical complications after myocardial infarction reliably predicted using C-reactive protein levels and lymphocytopenia

Cardiology

Volumn 99, Issue 1, 2003, Pages 25-31

  Widmer, Anouk ^a   Linka, André Z ^a   Attenhofer Jost, Christine H ^a   Buergi, Barbara ^a   Brunner La Rocca, Hans Peter ^a   Salomon, Franco ^b   Seifert, Burkhardt ^a   Jenni, Rolf ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

C reactive protein; Complications; Lymphocytopenia; Myocardial infarction; Rupture; Ventricular septal defect

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HEART INFARCTION; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RELIABILITY; RISK ASSESSMENT;

AGED; C-REACTIVE PROTEIN; FEMALE; HEART RUPTURE, POST-INFARCTION; HUMANS; LOGISTIC MODELS; LYMPHOCYTE COUNT; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 0037276481     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068448     Document Type: Article

References (28)

1. Dellborg M, Held P, Swedberg K, et al: Rupture of the myocardium. Occurrence and risk factors. Br Heart J 1985;54:11-16.
2. Lewis AJ, Burchell HB, Titus JL: Clinical and pathologic features of postinfarction cardiac rupture. Am J Cardiol 1969;23:43-53.
3. Naeim F, De la Maza LM, Robbins SL: Cardiac rupture during myocardial infarction. A review of 44 cases. Circulation 1972;45:1231-1239.
4. Mann JM, Roberts WC: Rupture of the left ventricular free wall during acute myocardial infarction: Analysis of 138 necropsy patients and comparison with 50 necropsy patients with acute myocardial infarction without rupture. Am J Cardiol 1988;62:847-859.
5. Anzai T, Yoshikawa T, Asakura Y, et al: Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction. J Am Coll Cardiol 1995;26:319-327.
6. Raitt MH, Kraft CD, Gardner CJ, et al: Subacute ventricular free wall rupture complicating myocardial infarction. Am Heart J 1993;126:946-955.
7. Shapira I, Isakov A, Burke M, et al: Cardiac rupture in patients with acute myocardial infarction. Chest 1987;92:219-223.
8. Anzai T, Yoshikawa T, Shiraki H, et al: C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997;96:778-784.
9. Dinarello CA: Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 1984;311:1413-1418.
10. Thomson SP, Gibbons RJ, Smars PA, et al: Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction. Ann Intern Med 1995;122:335-341.
11. Ueda S, Ikeda U, Yamamoto K, et al: C-reactive protein as a predictor of cardiac ruptur e after acute myocardial infarction. Am Heart J 1996;131:857-860.
12. Oliva PB, Hammill SC, Edwards WD: Cardiac rupture, a clinically predictable complication of acute myocardial infarction: Report of 70 cases with clinicopathologic correlations. J Am Coll Cardiol 1993;22:720-726.
13. Pierre RV, Payne BA, Lee WK, et al: Comparison of four leukocyte differential methods with the National Committee for Clinical Laboratory Standards (NCCLS) reference method. Am J Clin Pathol 1987;87:201-209.
14. Arrowood JA, Mohanty PK, Hodgson JM, et al: Ventricular sensory endings mediate reflex bradycardia during coronary arteriography in humans. Circulation 1989;80:1293-1300.
15. Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843.
16. Bates RJ, Beutler S, Resnekov L, et al: Cardiac rupture - Challenge in diagnosis and management. Am J Cardiol 1977;40:429-437.
17. O'Rourke MF: Subacute heart rupture following myocardial infarction. Clinical features of a correctable condition. Lancet 1973;ii:124-126.
18. Lopez-Sendon J, Gonzalez A, Lopez de Sa E, et al: Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: Sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria. J Am Coll Cardiol 1992;19:1145-1153.
19. Balakumaran K, Verbaan CJ, Essed CE, et al: Ventricular free wall rupture: Sudden, subacute, slow, sealed and stabilized varieties. Eur Heart J 1984;5:282-288.
20. Honan MB, Harrell FE Jr, Reimer KA, et al: Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis. J Am Coll Cardiol 1990;16:359-367.
21. Haskell WL: Physical activity after myocardial infarction. Am J Cardiol 1974;33:776-783.
22. Chaux A, Blanche C, Matloff JM, et al: Postinfarction ventricular septal defect. Semin Thorac Cardiovasc Surg 1998;10:93-99.
23. Kinn JW, O'Neill WW, Benzuly KH, et al: Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction. Cathet Cardiovasc Diagn 1997;42:151-157.
24. Crenshaw BS, Granger CB, Birnbaum Y, et al: Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000;101:27-32.
25. Bain RJ, Fox JP, Jagger J, et al: Serum cortisol levels predict infarct size and patient mortality. Int J Cardiol 1992;37:145-150.
26. Yamashita T, Abe S, Arima S, et al: Myocardial infarct size can be estimated from serial plasma myoglobin measurements within 4 hours of reperfusion. Circulation 1993;87:1840-1849.
27. Dissmann R, Linderer T, Schroder R: Estimation of enzymatic infarct size: Direct comparison of the marker enzymes creatine kinase and alpha-hydroxybutyrate dehydrogenase. Am Heart J 1998;135:1-9.
28. Albert MA, Danielson E, Rifai N, Ridker PM: PRINCE Investigators. Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation CRP evaluation (PRINCE): A randomized trial and cohort study. JAMA 2001;286:91-93.